BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11887505)

  • 1. The economic and social costs of lung cancer and the economics of smoking prevention.
    Godfrey C
    Monaldi Arch Chest Dis; 2001 Oct; 56(5):458-61. PubMed ID: 11887505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cost-effectiveness analysis of a community pharmacist-based smoking cessation programme in Thailand.
    Thavorn K; Chaiyakunapruk N
    Tob Control; 2008 Jun; 17(3):177-82. PubMed ID: 18285385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An economic analysis of tobacco elimination policies in Turkey.
    Arslanhan S; Caner A; Helvacioglu K; Saglam I; Teksoz T
    Health Policy; 2012 Jul; 106(2):149-60. PubMed ID: 22473246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical and pharmacological direct costs of a 9-week smoking cessation programme.
    Wasserfallen JB; Digon P; Cornuz J
    Eur J Prev Cardiol; 2012 Jun; 19(3):565-70. PubMed ID: 21450562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness of full coverage of the medical management of smoking cessation in France.
    Chevreul K; Cadier B; Durand-Zaleski I; Chan E; Thomas D
    Tob Control; 2014 May; 23(3):223-30. PubMed ID: 23197369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung-cancer reduction from smoking cessation and radon remediation: a preliminary cost-analysis in Northamptonshire, UK.
    Groves-Kirkby CJ; Timson K; Shield G; Denman AR; Rogers S; Phillips PS
    Environ Int; 2011 Feb; 37(2):375-82. PubMed ID: 21109305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of smoking on health care costs.
    Nair AK; Brandt EN
    J Okla State Med Assoc; 2000 Jun; 93(6):245-50. PubMed ID: 10860294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
    Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of smoking cessation programmes and a smoking ban in public places: comparing gain in life expectancy and cost effectiveness.
    Højgaard B; Olsen KR; Pisinger C; Tønnesen H; Gyrd-Hansen D
    Scand J Public Health; 2011 Dec; 39(8):785-96. PubMed ID: 21976052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):24-34. PubMed ID: 22406880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling the implications of regular increases in tobacco taxation in the tobacco endgame.
    Cobiac LJ; Ikeda T; Nghiem N; Blakely T; Wilson N
    Tob Control; 2015 Jun; 24(e2):e154-60. PubMed ID: 25145342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SmokingPaST Framework: illustrating the impact of quit attempts, quit methods, and new smokers on smoking prevalence, years of life saved, medical costs saved, programming costs, cost effectiveness, and return on investment.
    O'Donnell MP; Roizen MF
    Am J Health Promot; 2011; 26(1):e11-23. PubMed ID: 21879928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic issues in lung cancer: a review.
    Goodwin PJ; Shepherd FA
    J Clin Oncol; 1998 Dec; 16(12):3900-12. PubMed ID: 9850036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of tobacco control policies in Vietnam: the case of personal smoking cessation support.
    Higashi H; Barendregt JJ
    Addiction; 2012 Mar; 107(3):658-70. PubMed ID: 21883602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Economic evaluation of smoking cessation interventions: have we overlooked something].
    Trapero-Bertran M
    Arch Bronconeumol; 2009 May; 45(5):209-11. PubMed ID: 19395140
    [No Abstract]   [Full Text] [Related]  

  • 16. The economics of smoking and cardiovascular disease.
    Lightwood J
    Prog Cardiovasc Dis; 2003; 46(1):39-78. PubMed ID: 12920700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study.
    Feenstra TL; Hamberg-van Reenen HH; Hoogenveen RT; Rutten-van Mölken MP
    Value Health; 2005; 8(3):178-90. PubMed ID: 15877590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The health care costs of smoking.
    Barendregt JJ; Bonneux L; van der Maas PJ
    N Engl J Med; 1997 Oct; 337(15):1052-7. PubMed ID: 9321534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in health care costs before and after smoking cessation.
    Fishman PA; Thompson EE; Merikle E; Curry SJ
    Nicotine Tob Res; 2006 Jun; 8(3):393-401. PubMed ID: 16801297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economics of a reduction in smoking: case study from Heartbeat Wales.
    Phillips CJ; Prowle MJ
    J Epidemiol Community Health; 1993 Jun; 47(3):215-23. PubMed ID: 8350035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.